spectrometry-based techniques have been used for the first time to compare the metabolic composition of different ocular tissues. The metabolite composition of the retina of eyes kept at 4 o C post-mortem is mostly stable for at least 8 hours.
INTRODUCTION
Metabolites have many important roles in biological systems. 1 The total complement of metabolites in a biological system is defined as the metabolome; its composition is both sample-and time-dependent. 2, 3 As metabolites are the end product of biological pathways, the metabolome is a sensitive measure of disease phenotype and a dynamic indicator of genetic, environmental or disease-specific perturbations. 1, 4, 5 Metabolomics is increasingly being applied as a tool in eye research. It has been used to characterise normal ocular tissues and biofluids including the tear film, lens, vitreous and retina. [6] [7] [8] [9] [10] It has also been used to study ageing, a variety of ocular pathologies, metabolite transport in the retina, effects of drugs and metabolic changes during corneal organ culture for transplantation. [11] [12] [13] [14] [15] Aqueous and vitreous are the most accessible intraocular samples that can be obtained in clinical studies, and these have been used to interrogate the metabolic activities of surrounding ocular structures. 11, 15 However, it is unclear whether sampling ocular biofluids provides robust and reproducible information on the metabolic activity of surrounding tissues and ideally, the metabolome of the ocular tissue of interest should be studied directly. One option is to use post-mortem eyes.
However, a concern with this approach is that the concentration of metabolites can alter rapidly post-mortem caused by continued metabolic activity or metabolite instability. Time-dependent post-mortem biochemical changes have been demonstrated in donor cornea 16 and vitreous 17 , but to the best of our knowledge, there have been no published studies to date that objectively measure post-mortem changes in the retinal metabolome over time. This is important baseline information for future study design.
The objectives of the study reported here were (1) to investigate post-mortem changes in the rat retinal metabolome over 48 hours when eyes are stored at 4 o C (temperature at which human post-mortem eyes are stored in real-life) and (2) for the first time, annotate and characterise the metabolic composition of four ocular tissues (cornea, lens, vitreous and retina).
METHODS

Animals
All animal experiments were conducted in accordance with the United Kingdom (UK) Home Office regulations for the care and use of laboratory animals, the UK Animals (Scientific Procedures) Act (1986), and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Twenty-one, male, Sprague Dawley rats were included in the post-mortem study (42 eyes in total) and six rats were included in the tissue comparison study; all rats were in the age-range of 7-12 weeks. The rats were kept in the same room under standard laboratory conditions and fed with standard chow. The rats were culled by carbon dioxide inhalation followed by cervical extension; this process was staggered to ensure rapid sample collection. Enucleation was performed as soon as possible (between 1 to 20 minutes) after death. If eyes were not dissected immediately (T=0 hour samples), they were placed in small bottles and stored on ice before transferring to a refrigerator and then stored in the dark for up to 48 hours at 4°C (T=2-48 hour samples).
Dissection
Seven eyes were studied at each time point for the retinal metabolic stability study and six eyes were studied to annotate and characterise the metabolome of different ocular tissues . Dissections of the rat eyes at T=0 were performed   immediately after culling and the stored eyes were dissected at 2, 4, 8, 12, 24 and 48 hours post culling to remove the retina. Under microscope guidance the cornea was carefully removed. Then the iris was divided with forceps and the lens removed in one piece to gain access to the posterior segment. Vitreous was meticulously separated from the retina. Lastly, the neurosensory retina was removed avoiding contamination with the retinal pigment epithelium/Bruch's membrane/choroid complex. All dissections were performed on a cold plate to maintain a temperature of approximately 4 o C and dissection time was between 2 to 5 minutes. The dissected tissues were snap-frozen with liquid nitrogen and then stored at -80 o C before extraction.
Sample preparation
Each tissue sample was carefully weighed prior to extraction, mean weights were as follows; retina 25.4mg; vitreous 30.1mg; lens 32.7mg; cornea 7.9mg.
Metabolite extraction was achieved by adding 800μL of chloroform:methanol (50:50, pre-cooled to -20 o C) followed by 50μL of an internal standard mixture (0.1 mg/ml d 5 Benzoic acid, d 4 Succinic acid and d 5 Glycine dissolved in methanol) to each preweighed sample. Homogenisation/extraction was performed in a TissueLyser (Qiagen; 25Hz, 10 minutes using one 3mm tungsten carbide bead). Next, 400μL of water was added and the mixture was vortexed and allowed to stand on ice for 10 minutes. The samples were then centrifuged (5 minutes, 13,000g) to allow separation of the solvents. The top hydrophilic layer (to be analysed by GC-MS) and bottom lipophilic layer (to be used for UHPLC-MS analysis) were transferred into separate tubes and dried (Savant SPD131DDA with an RVT4104 cold trap, Thermo Scientific).
The volume of polar and non-polar extractions collected was normalised to the lowest tissue weight for each tissue type in each study. Quality control (QC) samples were prepared by pooling together an aliquot of 100μL from each retina sample after extraction and before drying. The QC samples were used for quality assurance as described by Dunn et al. 18 
UHPLC-MS analysis
All tissue extract samples and QC samples were reconstituted in 200µL 50:50 water:methanol prior to analysis. The samples were analysed using an Accela Ultra High Performance Liquid Chromatography system coupled to an electrospray hybrid LTQ-Orbitrap Velos mass spectrometer (ThermoFisher Scientific, Bremen, Germany). All samples were analysed separately in positive and negative ion modes.
QC samples were analysed for the first ten injections and then every fifth injection.
The last two injections were also QC samples. Chromatographic separations were performed, following injection of a 10μL sample volume, onto a Hypersil GOLD column (100x2.1mm, 1.9μm; ThermoFisher Scientific, Runcorn, UK) with the column temperature set at 50°C. The two solvents applied were solvent A -0.1% formic acid in water (vol/vol) and solvent B -0.1% formic acid in methanol (vol/vol)) at a flow rate of 400μL/min. Solvent A was held at 100% for 0.5 minutes followed by an increase to 100% solvent B over 4.5 minutes, which was then held at 100% solvent B for a further 5.5 minutes. At 10.5 minutes, it was changed to 100% solvent A and held at 100% solvent A to equilibrate for 1.5 minutes. All column eluent was transferred to the mass spectrometer. Full-scan profiling data were acquired in an Orbitrap mass analyser (mass resolution 30,000 at m/z =400).
Raw data files (.RAW format) generated from the UHPLC-MS system were converted to the NetCDF format using the File converter program in the XCalibur software package (ThemoFisher Scientific, Bremen, Germany). Deconvolution was performed using XCMS software 19 as described previously. 20 Whilst relative concentrations were measured no absolute quantification of metabolites to define concentrations per gram of tissue was performed. For quality assurance, only metabolite features detected in greater than 60% of QC samples and with a response not deviating greater than 20% from the QC mean were retained for further data analysis. All data was normalised to total peak area for each sample 18 . Annotation of the metabolite features detected in the UHPLC-MS system was performed by applying the PUTMEDID-LCMS set of workflows, as described previously. 21 
GC-MS analysis
All samples were chemically derivatised prior to analysis. 60µL of a 20mg/mL methoxylamine hydrochloride in dry pyridine solution was added to each sample. The samples were vortex mixed for 10s and heated for 20 minutes at 80°C. 60µL of N-methyl-N-trimethylsilyl-trifluoroacetamide was added and the samples were heated at 80°C for 20 minutes. After cooling, 20µL of a retention marker solution (n-alkanes C 10 , C 12 , C 15 , C 19 , C 22 , C 26 , C 28 , C 30 Raw instrument data were pre-processed applying the ChromaTof software (LECO; v4.22) using a previously described method and its associated chromatographic deconvolution algorithm, with the baseline set at 1.0, data point averaging of 3 and average peak width of 2.5. 18 The peak area was reported and the response ratio relative to the internal standard (peak area-metabolite/peak area-succinic-d 4 acid internal standard) was calculated. Whilst relative concentrations were measured no absolute quantification of metabolites to define concentrations per gram of tissue was performed. These data representing normalised peak lists were exported in .txt format. Most metabolites were definitively identified (MSI level 1), but a small number were putatively annotated (MSI level 2 or 3) according to The Metabolomics Standards Initiative reporting standards 22 by comparison of retention index and mass spectra acquired from the samples with those present in mass spectral libraries (NIST08, Golm Metabolome Database and Manchester Metabolomics Database). 21 Processed data were directly exported to Microsoft Excel® (.xls) worksheets for further data analysis.
Statistical analysis of retina stability
All statistical analyses were carried out using MetaboAnalyst. 23 All data were normalised to total peak area for each sample. Log 2 transformation was applied for univariate analysis to enhance a normal distribution in the datasets. KNN missing value imputation and Pareto scaling was applied for multivariate analysis only.
Metabolite features with greater than 50% missing values for the retinal stability study were removed prior to analysis. Univariate analysis applying one-way ANOVA and multivariate analysis (applying Principal Components Analysis (PCA)) were applied to data acquired from both studies. False discovery rate (FDR) was calculated applying the Benjamini-Hochberg procedure, 24 q<0.05 was used to determine the statistical significance. FDR applies a statistical approach to correct for multiple testing in large datasets and to control the expected number of false positives.
Comparison of the metabolome of different ocular tissues
Six biological replicates for each tissue type were analysed by applying GC-MS and UHPLC-MS and the metabolites were putatively annotated or identified as described above. For putatively annotated metabolites reported more than once (as multiple metabolite features with the same retention time but different mass-tocharge ratios) the entry with the highest total peak area sum across all four tissue types was retained while all other duplicates were deleted. Applying this dataset of unique metabolite annotations, the number of metabolites observed in each combination of tissue type was calculated.
Results
Post-mortem change in the rat retina metabolome
All data analysis used relative peak areas. The absolute concentrations for all metabolites were not determined as this is not technically feasible for the thousands of metabolites detected in non-targeted metabolomics studies where the metabolome composition is not known prior to data acquisition, as many metabolites are not available to prepare calibration solutions.
Unsupervised multivariate PCA analysis scores plots of the GC-MS data ( Figure 1 ) and the UHPLC-MS data ( Figure 2 ) showed no separation of retinal samples for eyes stored for 0, 2, 4 and 8 hours, whereas samples stored for 24 and 48 hours were clearly separated. These results imply that samples stored at 4°C are largely metabolically stable for the first 8hrs, but that multiple changes in the metabolic composition commence after that.
Univariate one-way ANOVA was applied to identify those metabolite features that demonstrated a statistically significant difference in relative concentrations between these time points. 16 identified and 133 annotated metabolite features were statistically significant (q<0.05) for GC-MS and UHPLC-MS, respectively. Analysis of the GC-MS data revealed increases in the concentration of two metabolites present in the TCA cycle from 2 hours post mortem (namely citrate and malate), increases in six and a decrease in one amino acid from 8 hours post mortem and decreased levels of five fatty acids from 24 hours post mortem. (Table 1 ) More detailed information on these data is available in Supplementary Information 1. Analysis of metabolites detected by UHPLC-MS showed that 10 classes of metabolites underwent statistically significant (q<0.05) changes post mortem including acyl carnitines (10), diacylglycerides (12) , aromatic amino acids (3), bile acids (7), ceramides and sphingolipids (9), fatty acids/fatty alcohols/fatty amides (16) , glycerophospholipids (33), lysoglycerophospholipids (18), steroid hormones (5) and vitamin D metabolites (7) . These data are available in Supplementary Information 2.
As observed for GC-MS, different metabolites and metabolite classes showed different periods of stability. For example, acyl carnitines showed a change in concentration from as early as two hours, bile acids from 4 hours and aromatic amino acids from 24 hours. Some classes showed that metabolites within each class showed different levels of stability. Box and whisker plots for 4 exemplar metabolites are shown in Figure 3 .
Characterisation of rat cornea, lens, vitreous and retina metabolome
GC-MS
A total of 42 unique metabolites were identified according to MSI reporting level 1 (i.e. identified metabolites). 20 were detected in the cornea, 32 in the lens, 19
in the vitreous and 21 in the retina. 1, 13, 2 and 3 unique metabolites were detected only in the cornea, lens, vitreous or retina, respectively. The metabolites may have been present at concentrations lower than the detection limits of the analytical methods applied and therefore this method qualitatively defines differences in concentrations and not necessarily the presence or absence of a metabolite at any concentration. (See Table 2 for the list of metabolites detected in the tissues.)
UHPLC-MS
There were a total of 2782 unique metabolites detected in one or more tissue (cornea, lens, vitreous and retina). The majority of metabolites are annotated according to MSI level 2 (i.e. putatively annotated compounds). Many of these were detected in all or most of the tissues with 443 metabolites being common to all tissues. 93, 297, 13 and 655 metabolites were found only in cornea, lens, vitreous and retina respectively. Only 13 of 1261 (1%) metabolites detected in vitreous were unique to vitreous, whereas 655 of 1942 (34%) of metabolites detected in retina were unique to retina. 1.6% of metabolites found in the vitreous were uniquely found in the retina and not other tissues. The list of metabolites detected in the tissues studied can be found in Supplementary Information 3. The Venn diagram in Figure 4 illustrates the distribution of these metabolites across the four tissues. As can be seen a large list of putatively annotated metabolites were detected in one or more tissue. The aim of this study was not to provide a list of all metabolites in each tissue but rather to provide an overview of the similarities and differences in the metabolomes across the four different ocular tissues. Many different classes of metabolites were detected including acyl carnitines, acyl glycerides, amino acids, ceramides and sphingolipids, fatty acids, fatty amides, glycerophospholipids, lysoglycerophospholipids, iodo-and fluoro-metabolites, nucleosides/nucleotides, oxidative phosphorylation, steroid hormones and vitamin D metabolites.
Discussion
Two complementary MS techniques where used in this study: GC-MS that detects small polar metabolites, and UHPLC-MS that detects non-polar metabolites, specifically lipids. The analysis of post-mortem changes in the rat eye was undertaken to establish protocols for the metabolomic analysis of eye tissue from animal models and to explore whether it may be feasible to use human ocular tissue for metabolic studies and if so how quickly it would need to be processed. Univariate and multivariate analysis of data acquired applying GC-MS and UHPLC-MS demonstrated that the metabolic composition of the rat retina remained largely stable for the first 8 hours post-mortem when maintained at 4 o C, but thereafter an increasing proportion of metabolites changed in relative concentration. A small number of metabolites showed changes in their concentration from 2 hours, including two metabolites present in the TCA cycle. These metabolites (citrate and malate) increased in concentration, suggesting a reduction in their catabolism and/or an increase in their synthesis. Citrate and malate can be both the substrates and products of the TCA cycle. The TCA cycle consists of sequential reversible, and irreversible chemical reactions, in which its directionality depends on the state of oxygen in the tissue. 25 In anaerobic conditions, oxaloacetate can be converted into malate and this may explain the increased in concentration in our post-mortem retina. 26, 27 In fact, malate has been found to increase 4-fold in cardiac ischaemia. 28 Citrate is used as a substrate only in aerobic conditions towards the synthesis of alpha-ketaglutarate. In anaerobic conditions, backflux may occur and citrate accumulates as a product of the cycle. 29, 30 If the theory of increase in synthesis were true to account for the increased concentration of these 2 metabolites, it suggests that TCA cycle continues in anaerobic condition over 48 hours in the rat retina when stored at 4 O C. An earlier study showed that post-mortem retinas can retain their metabolic capacities for 4-4 1/2 hours following death and this capacity is increased when the tissue is kept at 4 o C 31 but to the best of our knowledge, there are no studies that look at the TCA cycle in post-mortem rat retina. However, it is also likely the increased in concentration of citrate and malate is a result of reduced TCA cycle and hence, reduced consumption of the metabolites. Other metabolites such as the amino acids (leucine, methionine, phenylalanine, tryptophan) were largely stable in the first 24 hours post-mortem but followed an increasing trend over the 48hrs time period. Many of the neurotransmitters required for normal retinal cell function occur as free amino acids in the retina. Most of them are generated from the intermediates in the TCA cycle 32 , suggesting that the TCA cycle is on-going during this period but consumption of the metabolites by the retinal cells may be reduced due to an overall decrease in metabolic activity in hypoxic conditions, hence the increased in its concentration. Further studies are required to investigate other metabolites involved in the TCA cycle under different temperatures.
The level of glutamate, on the other hand, falls over post-mortem time.
Glutamate is an excitatory neurotransmitter in the brain and retina. Studies have shown an increased extracellular level of glutamate in cerebral ischaemia. 33, 34 An elevated glutamate level was also found in the vitreous of eyes with glaucoma, thought to be indicative of retinal ganglion cell death. 35 It is uncertain why the glutamate level in our study decreases over post-mortem time where severe hypoxia can be assumed. It may be that the equilibrium favours the synthesis of alphaketaglutarate from glutamate in the TCA cycle in the state of hypoxia when the temperature is low.
Uracil, a nucleobase in the nucleic acid of RNA was also found increase in concentration. Similar trend was observed in post-mortem porcine vitreous humour. 36 Ascorbic acid and some of the fatty acids decreased in concentration over time. This is most likely due to an overall reduced synthesis and increased consumption.
Ascorbic acid is an antioxidant and it is unsurprising that the level plummets in hypoxic conditions. It should be noted that samples were collected within 20 minutes of death and that a small level of metabolic activity could remain present during this time. This implies that the T=0 samples are potentially not identical to the metabolome at death; however, the authors believe that these changes will be small compared to the metabolic changes observed at later time points. Based upon these experiments we conclude that post-mortem human tissue would need stabilisation within 8 hours following enucleation and storage at 4 O C to be used for metabolomics studies and that tissue retrieved following surgery could be used if appropriate protocols are in place to quickly stabilise it for metabolomics studies.
A large number of metabolites were identified (to MSI level 1) or annotated (to MSI level 2) in the cornea, lens, vitreous and retina using MS-based techniques; 42 and 2782 for GC-MS and UHPLC-MS respectively. We decided to analyse the watersoluble metabolites applying GC-MS though the application of UHPLC-MS applying a HILIC column would allow a greater number of water-soluble metabolites to be detected. The data acquired show that some identified/annotated metabolites were uniquely detected in only one tissue, whereas many others were detected in two or more tissues. The retina displayed the most unique profile of identified/annotated metabolites with 655 detected only in this tissue. The cornea and vitreous contained fewer unique identified/annotated metabolites. Interestingly, only a small percentage (1.6%) of identified/annotated metabolites found in the vitreous were exclusively found in the retina and not other tissues. Vitreous is composed of approximately 98% water, 1% macromolecules including collagen, hyaluronan and soluble protein and low molecular weight molecules including metabolites that are derived from adjacent ocular tissues and blood plasma. 37 There is metabolic exchange between the cornea and aqueous, and the lens with vitreous and aqueous; so the movement of metabolites between these compartments may explain the similarities between the metabolites found in the lens, vitreous and cornea. However, there is a bulk flow of water posteriorly from the vitreous through the retina 38 and this uni-directional anterior to posterior flow may inhibit the anterior movement of small molecules from the retina into the vitreous resulting in the vitreous metabolome not reflecting that of the retina. Vitreous has been used as the surrogate for analysing molecular changes taking place in the retina, but this study suggests that metabolic footprinting of vitreous may not always be informative with respect to metabolic activity in the retina.
However, in some pathological states where there is increased permeability of the retinal vessels or RPE, vitreous analysis may be of value. This study provides a guide to the classes of common metabolites that can be expected either exclusively or non-exclusively across different ocular tissues and serve as valuable baseline knowledge to future studies. For example, one of the common metabolites detected in both the retina and vitreous only in our study was urate. Baban et al 39 found an increased in purine metabolism in the diabetic retina that corresponded to an increased vitreal urate level. We also know from our study that urate can be detected in the vitreous. Hence, studies looking at vitreal urate level will always need to include a control group to measure differences in concentration. On the other hand, we know that vitreous sample would not be a good surrogate in studies looking at certain metabolites that were found exclusively identified in the retina (ie. Retinal palmitate, an antioxidant), in physiological states at least.
In conclusion, applying metabolomics to ocular tissues is likely to become an increasingly important technique for studying diseases of the eye, identifying biomarkers and investigating the effects of therapeutic interventions. However, caution must be applied when assuming that sampling of ocular biofluids will give insights into the metabolome of adjacent tissue structures. When analysing the metabolome of ocular tissue post-mortem, it is important to recognise that there are time-dependent post-mortem changes, which will make it challenging to use human tissue, although if stringent methodologies are applied, metabolomics could be a very valuable approach in animal models. 
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